MiR-138-5p targeting LIMK1 suppresses breast cancer cell proliferation and motility

被引:8
作者
Li, Dengfeng [1 ]
Song, Hongming [1 ]
Wu, Tianqi [1 ]
Xie, Dan [1 ]
Hu, Jiashu [1 ]
Zhao, Junyong [1 ]
Fang, Lin [1 ]
机构
[1] Tongji Univ, Sch Med, Dept Thyroid & Breast, Gen Surg,Shanghai Peoples Hosp 10,Jingan Area, 301 Yanchang Middle Rd, Shanghai 200072, Peoples R China
基金
中国国家自然科学基金;
关键词
ARYL UREA DERIVATIVES; METASTASIS; GROWTH; INHIBITORS; INVASION; IDENTIFICATION; PROGRESSION; DISCOVERY; THERAPY; MARKERS;
D O I
10.1039/c7ra09042k
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Breast cancer is the most frequently diagnosed female cancer. LIM domain kinase 1 (LIMK1) was reported to increase breast cancer progressive biological behavior and was associated with clinical breast cancer outcomes. MiRNAs are a kind of small non-coding RNA that binds the target mRNAs, leading to protein downregulation. The aim of this study was to find whether miR-138-5p could target LIMK1 in breast cancer to suppress breast cancer biological behavior. The TCGA database showed that LIMK1 was highly expressed in breast cancer. The dual-luciferase report showed that LIMK1 was a target gene of miR-138-5p. Over-expression of miR-138-5p could significantly reduce expression of LIMK1 in mRNA and the protein level. Colony formation and MTT assay showed that over-expression of miR-138-5p could suppress proliferation of breast cancer cells. Wound-healing assay and transwell assay showed that over-expression of miR-138-5p could suppress migration and invasion of breast cancer cells. In addition, over-expression of miR-138-5p could arrest breast cancer cells into the G0/G1 phase by down-regulating expression of CDK4, 6/Cyclin D1 and CDK2/Cyclin E1 compounds. In conclusion, our study showed that miR-138-5p could target LIMK1 and suppress the progressive biological behavior of breast cancer cells. Mi-138-5p targeting LIMK1 may be a new potential treatment for breast cancer.
引用
收藏
页码:52030 / 52038
页数:9
相关论文
共 42 条
[1]  
Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
[2]   LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system [J].
Bagheri-Yarmand, R ;
Mazumdar, A ;
Sahin, AA ;
Kumar, R .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) :2703-2710
[3]   Lim kinases, regulators of actin dynamics [J].
Bernard, Ora .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (06) :1071-1076
[4]   Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors [J].
Bologna-Molina, Ronell ;
Mosqueda-Taylor, Adalberto ;
Molina-Frechero, Nelly ;
Mori-Estevez, Ana-Dolores ;
Sanchez-Acuna, Guillermo .
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2013, 18 (02) :E174-E179
[5]   Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications [J].
Campos-Parra, Alma D. ;
Cuamani Mitznahuatl, Gerardo ;
Pedroza-Torres, Abraham ;
Vazquez Romo, Rafael ;
Porras Reyes, Fany Iris ;
Lopez-Urrutia, Eduardo ;
Perez-Plasencia, Carlos .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (06)
[6]   Discovery, Development, and SAR of Aminothiazoles as LIMK Inhibitors with Cellular Anti-Invasive Properties [J].
Charles, Mark D. ;
Brookfield, Joanna L. ;
Ekwuru, Tennyson C. ;
Stockley, Martin ;
Dunn, John ;
Riddick, Michelle ;
Hammonds, Tim ;
Trivier, Elisabeth ;
Greenland, Gavin ;
Wong, Ai Ching ;
Cheasty, Anne ;
Boyd, Susan ;
Crighton, Diane ;
Olson, Michael F. .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (20) :8309-8313
[7]  
Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431
[8]   Discovery of bis-aryl urea derivatives as potent and selective Limk inhibitors: Exploring Limk1 activity and Limk1/ROCK2 selectivity through a combined computational study [J].
Cui, Jiaxin ;
Ding, Mei ;
Deng, Wei ;
Yin, Yan ;
Wang, Zhonghua ;
Zhou, Hong ;
Sun, Guofeng ;
Jiang, Yu ;
Feng, Yangbo .
BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (23) :7464-7477
[9]  
Fisher Robert P, 2016, F1000Res, V5, P2374
[10]   Multiple-to-Multiple Relationships between MicroRNAs and Target Genes in Gastric Cancer [J].
Hashimoto, Yutaka ;
Akiyama, Yoshimitsu ;
Yuasa, Yasuhito .
PLOS ONE, 2013, 8 (05)